Synthesis of Ins(1,3,4,5,6)P5 from Ins(1,4,5)P3 in mammals. In the abbreviations of the chemical structures, “Ins” indicates the myo-inositol skeleton. The number of monophosphates around the inositol ring is denoted as a suffix after the “P.” The figure shows two pathways (ITPK1-dependent and -independent) by which mammalian cells convert Ins(1,4,5)P3 to Ins(1,3,4,5,6)P5. It is unclear which of the two routes of Ins(1,3,4,5,6)P5 synthesis is quantitatively the more important. IP3K, Ins(1,4,5)P3 kinase; IPMK, inositol polyphosphate multikinase (also known as Ipk2 in yeast); 5-PASE, Ins(1,4,5)P3/Ins(1,3,4,5)P4 5-phosphatase; ITPK1, inositol trisphosphate kinase. There is phylogenetic variability in the isomeric nature of the InsP4 produced by Ins(1,4,5)P3 phosphorylation by IMPK: it is mainly Ins(1,3,4,5)P4 in mammals, mainly Ins(1,4,5,6)P4 in yeasts, and IPK2 from D. melanogaster synthesizes almost equal amounts of both InsP4 isomers (Seeds et al., 2004). Note that yeasts and D. melanogaster do not encode ITPK1 in their genomes (Seeds et al., 2004). Finally, plants (Brearley and Hanke, 1996) and slime molds (Stephens and Irvine, 1990) can synthesize Ins(1,3,4,5,6)P5 by alternate metabolic pathways that do not use Ins(1,4,5)P3.